|
KMID : 0379520000160040293
|
|
한국독성학회지
2000 Volume.16 No. 4 p.293 ~ p.301
|
|
|
Chronic Toxicity of a Combined Preparation of Ticlopidine and Ginkgo Biloba Extract (EGb 761) Orally Administered to Rats for 13 Consecutive Weeks
|
|
Kim Sang-K.
Kim Sung-Y.
Yoon Mi-Y.
Oh Soo-J.
Kim Hye-S.
Lee Ja-Y.
Kang Sung-A.
Lee Kyung-H.
Kim Young-C.
|
|
|
Abstract
|
|
|
|
Toxicity of a combined preparation of ticlopidine and ginkgo biloba extract (EGb 761) in a ratio of 10: 4 was examined in male and female Sprague-Dawley rats. Rats were treated with the test substance intragastrically at a dose of 0 mg/kg, 17 mg/kg, 52 mg/kg or 156 mg/kg for 91 consecutive days. No death or abnormal clinical sign was observed throughout the administration period. There was no difference in body weight gain, food intake or water consumption among different dose groups. Test sub-stance-related differences were not observed in urinalysis. In hematological results mean corpuscular hemoglobin (MCH) of low and high dose male group was increased. Prothrombin time of medium and high dose female group was decreased. A significant increase in serum total cholesterol was observed in both sexes of rats treated with a daily dose of 156 mg/kg, but all the other values obtained in serum chemistry appeared to be within normal ranges. A dose dependent increase in the relative liver and kidney weights was observed in both male and female rats. There were no gross pathological findings at terminal sacrifice. Microscopic histopathological examination did not show any lesion associated with administration of the test substance. The results suggest that under the conditions employed in this study no observable effect level (NOEL) of the test substance be greater than 17 mg/kg/day, but less than 52 mg/kg/day.
|
|
|
KEYWORD
|
|
|
Ticlopidine, Ginkgo biloba extract, Chronic toxicity, Rats
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
 
|